Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Amoxicillin/Clavulanic Acid-Induced Thrombocytopenia

View through CrossRef
Introduction and Objective Drug-induced thrombocytopenia is a common adverse effect reported in the literature. Typically patients present with a low platelet count with signs and symptoms ranging from bruising to bleeding, and major organ damage. Penicillin-induced thrombocytopenia previously reported in the literature is explained primarily through the hapten-dependent antibody process. The goal of this report is to present a case of an amoxicillin/clavulanic acid-induced thrombocytopenia. Case Presentation A 23-year-old male presented to the emergency department with bruises on his arms and legs after completing a full course of amoxicillin/clavulanic acid of 625 mg twice a day for 5 days for tonsillitis. After several tests, the patient was diagnosed with thrombocytopenia induced by amoxicillin/clavulanic acid. The patient was treated with a corticosteroids taper regimen for 3 weeks. He was discharged after 3 days of inpatient treatment with instructions to avoid physical activity for 2 weeks. Two weeks post discharge, the follow-up showed that the platelet count had increased. Discussion Penicillin-induced thrombocytopenia has been previously reported in the inpatient setting where bleeding was observed. However, the patient in this case report presented with bruises on his arms and legs. The diagnosis was made by the process of elimination; not all possible tests were conducted. The patient was prescribed corticosteroids that are not indicated for drug-induced thrombocytopenia. The Naranjo scale showed that this is a probable adverse event of amoxicillin/clavulanic acid. Conclusion This is a unique case where amoxicillin/clavulanic acid was reported to be a probable cause of thrombocytopenia in an outpatient setting without signs of bleeding and without concomitant medications.
Title: Amoxicillin/Clavulanic Acid-Induced Thrombocytopenia
Description:
Introduction and Objective Drug-induced thrombocytopenia is a common adverse effect reported in the literature.
Typically patients present with a low platelet count with signs and symptoms ranging from bruising to bleeding, and major organ damage.
Penicillin-induced thrombocytopenia previously reported in the literature is explained primarily through the hapten-dependent antibody process.
The goal of this report is to present a case of an amoxicillin/clavulanic acid-induced thrombocytopenia.
Case Presentation A 23-year-old male presented to the emergency department with bruises on his arms and legs after completing a full course of amoxicillin/clavulanic acid of 625 mg twice a day for 5 days for tonsillitis.
After several tests, the patient was diagnosed with thrombocytopenia induced by amoxicillin/clavulanic acid.
The patient was treated with a corticosteroids taper regimen for 3 weeks.
He was discharged after 3 days of inpatient treatment with instructions to avoid physical activity for 2 weeks.
Two weeks post discharge, the follow-up showed that the platelet count had increased.
Discussion Penicillin-induced thrombocytopenia has been previously reported in the inpatient setting where bleeding was observed.
However, the patient in this case report presented with bruises on his arms and legs.
The diagnosis was made by the process of elimination; not all possible tests were conducted.
The patient was prescribed corticosteroids that are not indicated for drug-induced thrombocytopenia.
The Naranjo scale showed that this is a probable adverse event of amoxicillin/clavulanic acid.
Conclusion This is a unique case where amoxicillin/clavulanic acid was reported to be a probable cause of thrombocytopenia in an outpatient setting without signs of bleeding and without concomitant medications.

Related Results

Bleeding in neonates with severe thrombocytopenia: a retrospective cohort study
Bleeding in neonates with severe thrombocytopenia: a retrospective cohort study
Abstract Background Severe neonatal thrombocytopenia is a rare disease with multiple etiologies. Severe thrombocytopenia with bleeding is life-threa...
Frequency of Thrombocytopenia in Malaria and its prognostic significance
Frequency of Thrombocytopenia in Malaria and its prognostic significance
BACKGROUND & OBJECTIVE: Thrombocytopenia is a common hematological manifestation of malaria, but locally there is limited data on the association of thrombocytopenia degree and...
Thrombocytopenia and its Severity in Plasmodium Vivax Positive Patients
Thrombocytopenia and its Severity in Plasmodium Vivax Positive Patients
Background: Plasmodium vivax, one of the four species of human malaria parasites, is responsible for a considerable portion of malaria cases. While P. vivax is often considered les...
Case Report: Maggots' Infestation As a Predisposing Condition for Heparin-Induced Thrombocytopenia, a Newest Entity
Case Report: Maggots' Infestation As a Predisposing Condition for Heparin-Induced Thrombocytopenia, a Newest Entity
Abstract Introduction Thromobocytopenia is a well-recognized complication of heparin with risk of venous or arterial thrombosis. Heparin induced throm...
SEVERE THROMBOCYTOPENIA POST PCI: HEPARIN-INDUCED VS GP IIB/IIIA INHIBITOR-INDUCED
SEVERE THROMBOCYTOPENIA POST PCI: HEPARIN-INDUCED VS GP IIB/IIIA INHIBITOR-INDUCED
Background: Thrombocytopenia is a clinically relevant complication in patients undergoing Percutaneous Coronary Intervention (PCI) or treated for Acute Coronary Syndrome (ACS), par...
Thrombocytopenia and clinical outcomes among patients with COVID‐19 disease: A cohort study
Thrombocytopenia and clinical outcomes among patients with COVID‐19 disease: A cohort study
AbstractBackground and AimsThrombocytopenia is increasingly recognized among patients with critical illness and plays a role in several diseases affecting different organ systems. ...
Investigating thrombocytopenia in Meropenem-treated patients: a cross-sectional observational study
Investigating thrombocytopenia in Meropenem-treated patients: a cross-sectional observational study
Abstract Meropenem is frequently employed empirically to treat both single and polymicrobial infections. In clinical practice, meropenem injections have been shown to ind...

Back to Top